Medinex Limited (OTX) Fair Value & Analysis
Healthcare · SG · Market cap 30.9M SGD
Fair value as of: Jul 4, 2026
From 22 valuation models · updated yesterday
Share price −8.0% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.2048 SGD – 0.2500 SGD · fair‑value band 0.2400 SGD – 0.4500 SGD · the 0.2300 SGD price screens below the 0.3200 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Medinex Limited (OTX) currently trades at 0.2300 SGD, while our model-based Fair Value estimate is 0.3200 SGD — implying the stock looks roughly 39.1% undervalued today. We read business quality at 70/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Medinex Limited generated revenue of 12.4M SGD at a net margin of 17.9%. Revenue declined 3.0% year over year. It earns a return on equity of 13.4%. The stock trades on a trailing P/E of 11.5. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Medinex Limited, an investment holding company, provides professional support services to medical clinics in Singapore. It operates through four segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. The company engages in the setting up of clinics, facilitating applications for relevant clinic licenses, value added services to healthcare sectors, turnkey solutions, as well as strategic advice to general practitioners and specialists on establishing clinic facilities. It also provides accounting and tax agent, human resource management, and corporate secretarial services, as well as business support services, such as accounting, tax agent, human resource management, and corporate secretarial services to various sectors, such as food and beverage, retail, education, and beauty. In addition, the company procures medical and pharmaceutical products to clinics. Further, the company offers diagnostic and x-rays, pre-employment …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Medinex Limited reported revenue of 12.4M SGD in FY2026 versus 12.0M SGD in FY2022, a compound +0.9%/yr. Reported net income was 2.2M SGD in FY2026, compounding −5.7%/yr from FY2022.
Is OTX fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.67 MYR | 3.08 MYR | -64% |
| IHHHF IHHHF | $1.71 | $0.7400 | -57% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Medinex Limited (OTX) undervalued?
What is the fair value of OTX?
What is the quality score of OTX?
What is the revenue of Medinex Limited (OTX)?
What is the net profit margin of OTX?
Does Medinex Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.